Latest News
FDA Authorizes COVID-19 Test That Provides Rapid Results at Home
High-Dose Flu Vaccine More Effective for Patients With HIV
People With HIV May Have a Higher Susceptibility to COVID-19
Fluvoxamine Evaluated in Patients With Mild COVID-19
Higher Neutrophil Count Linked to Mortality in Systemic Sclerosis-Related Interstitial Lung Disease
Venous Thromboembolism Rates in Patients With SARS-CoV-2 Infection
Novavax COVID-19 Vaccine Candidate Fast Tracked
Rising Trend of Obstructive Sleep Apnea in the Aging HIV Population
Hospital Mortality Higher in Critically Ill Patients With COVID-19 vs Influenza
A Potential Prognostic Marker for PAH
Use of Ikari-Curve Left Guiding Catheters During Balloon Pulmonary Angioplasty May Improve Branch Access
Pulmonary Vein Sign to Assess Chronic Thromboembolic Pulmonary Hypertension
Tezepelumab Improves Asthma Control, Health-Related Quality of Life
Prevalence of Pulmonary Hypertension in Patients With Myeloproliferative Neoplasms
Latest Features
-
BCG Tuberculosis Vaccine: Potential Protection Against COVID-19
Findings suggest lower rates of COVID-19 infection and mortality in countries with universal neonatal BCG tuberculosis vaccination policies compared with countries without this practice. -
Pulmonary Fibrosis Awareness Month: Spotlight on the PFF Care Center Network
As a central goal of PF Awareness Month and their ongoing work, the Pulmonary Fibrosis Foundation aims to improve diagnostic delays and misdiagnoses in this patient population. -
Antiplatelet Therapy in COPD May Reduce All-Cause Mortality, Improve Quality of Life
Antiplatelet therapy may delay progression of COPD, decrease the risk for acute exacerbations, improve quality of life, and even reduce all-cause mortality. -
Effect of COVID-19 on Pulmonary Fibrosis Clinical Trials: Expert Interview
Individuals with pulmonary fibrosis could develop more serious complications if infected with COVID-19, and those awaiting organ transplantation and other surgical interventions may face delays because of the pandemic. -
Obstructive Sleep Apnea as a Potential Risk Factor for COVID-19: Expert Interview
Obstructive sleep apnea may represent another important variable contributing to increased risk related to COVID-19. -
Lung Cancer in the Time of COVID-19: Challenges and Solutions
In the midst of the COVID-19 pandemic, patients with lung cancer face an increased risk of disease progression, reduced survival, and worse quality of life associated with delayed treatment.
Latest Features
ASH 2020 Guidelines on Venous Thromboembolism Management
The American Society of Hematology released evidence-based guidelines for the treatment of DVT and PE in patients without cancer.
COVID-19 Vaccine Allocation: Ethical Concerns, Practical Challenges
In the event of a likely scarcity of COVID-19 vaccines, a framework must be developed to inform who should get priority.
Discussing Influenza and Pneumococcal Vaccines With Patients During COVID-19
How should physicians be discussing influenza and pneumococcal vaccines with patients amidst the continuing COVID-19 pandemic?
-
Loading...
-
Loading...
